INTERNATIONAL PATENT: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "IMMUNE MODULATION FOR THE TREATMENT OF TYPE 1 DIABETES"

GENEVA, April 21 -- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (210 West 7th StreetAustin, Texas 78701) filed a patent application (PCT/US2024/050774) for "IMMUNE MODULATION FOR THE TREATMENT OF TYPE 1 DIABETES" on Oct 10, 2024. With publication no. WO/2025/080834, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Andrew (5323 Harry Hines BoulevardDallas, Texas 75390), RUAN, Lifu (5323 Harry Hines BoulevardDallas, Texas 75390), PETERS, Jonathan (5232 Harry Hines BoulevardDallas, Texas 75390), MAN AU, Kin (...